Etanercept-associated SLE with lupus nephritis

Lupus

Volumn 18, Issue 7, 2009, Pages 667-668

  Neradova A ^a   Stam, F ^a   van den Berg, J G ^b   Bax, W A ^a  

^a Location Alkmaar   (Netherlands)

^b ZAANS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3C; CREATININE; DOXYCYCLINE; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; CASE REPORT; CREATININE CLEARANCE; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PERICARDITIS; PERIORBITAL EDEMA; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; RHEUMATOID ARTHRITIS; SINUSITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; WEIGHT GAIN;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65649084842     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308100560     Document Type: Letter

References (7)

1. Charles PJ, Smeenk RJ, De Jong J, Feldman M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: Findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000; 43: 2383-2390.
2. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
3. Gewurtz H, Zhang XH, Lint TF. Structure and function of the pentraxins. Curr Opin Immunol 1995; 7: 54-64.
4. Bicerstaff MC, Botto M, Huntchinson WL, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999; 5: 694-697.
5. De Brandt M, Sibilia J, Le Loet X, et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey. Arthritis Res Ther 2005; 7: 445-R451.
6. Ramos-Casals M, Brito-Zerón P, Munoz S, et al. Autoimmune diseases induced by TNF-targeted therapies: Analysis of 233 cases. Medicine (Baltimore) 2007; 86: 242-251.
7. Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor alfa blockade in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3161-3169.